Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
respiratory syncytial virus
Pharma
GSK CEO still sees plenty of 'headroom for growth' for RSV shot
Despite Arexvy's swift takeoff, there’s still “lots of headroom for growth," GSK's CEO Emma Walmsley said during a Reuters interview Thursday.
Fraiser Kansteiner
Nov 30, 2023 4:32pm
Senate Democrats demand answers around Beyfortus shortage in US
Nov 20, 2023 2:06pm
GSK crushed Pfizer in first round of RSV vaccine showdown
Nov 1, 2023 10:43am
Pfizer's RSV shot Abrysvo sees solid uptake as COVID sales crash
Oct 31, 2023 2:08pm
Sanofi, AZ's Beyfortus in short supply as RSV season kicks up
Oct 24, 2023 3:02pm
CDC backs Pfizer's maternal Abrysvo to protect infants from RSV
Sep 25, 2023 11:08am
